NASDAQ:PDEX Pro-Dex (PDEX) Stock Price, News & Analysis $62.19 -1.30 (-2.05%) Closing price 03:59 PM EasternExtended Trading$63.66 +1.47 (+2.36%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About Pro-Dex Stock (NASDAQ:PDEX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Pro-Dex alerts:Sign Up Key Stats Today's Range$61.96▼$63.5850-Day Range$57.65▼$73.0252-Week Range$30.55▼$77.00Volume45,469 shsAverage Volume50,190 shsMarket Capitalization$199.01 millionP/E Ratio17.04Dividend YieldN/APrice Target$80.00Consensus RatingModerate Buy Company Overview Pro-Dex, Inc. designs, develops and manufactures powered surgical instruments and related accessories, with a focus on devices used in orthopedic procedures. Its products include surgical handpieces and drivers, along with the components and systems that support their operation. The company also provides engineering, product development and manufacturing services to medical device companies. Its work can span the product lifecycle, from design and prototyping to production and servicing. Founded in 1978, Pro-Dex is headquartered in Irvine, California, and serves customers in the United States and international markets.AI Generated. May Contain Errors. Read More Pro-Dex Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks78th Percentile Overall ScorePDEX MarketRank™: 3.92299260071 of 5 starsPro-Dex scored higher than 78% of companies evaluated by MarketBeat, and ranked 104th out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.9 / 5Analyst RatingModerate Buy Consensus RatingPro-Dex has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and no sell ratings.Upside PotentialPro-Dex has a consensus price target of $80.00, representing about 28.8% upside from its current price of $62.11.Amount of Analyst CoveragePro-Dex has only been the subject of 3 research reports in the past 90 days.Read more about Pro-Dex's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth8.74% Earnings GrowthEarnings for Pro-Dex are expected to grow by 8.74% in the coming year, from $3.09 to $3.36 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Pro-Dex is 17.02, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.47.Price to Earnings Ratio vs. SectorThe P/E ratio of Pro-Dex is 17.02, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.68.Price to Book Value per Share RatioPro-Dex has a P/B Ratio of 4.03. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Pro-Dex's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted16.31% of the float of Pro-Dex has been sold short.Short Interest Ratio / Days to CoverPro-Dex has a short interest ratio ("days to cover") of 7.42.Change versus previous monthShort interest in Pro-Dex has recently increased by 15.01%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPro-Dex does not currently pay a dividend.Dividend GrowthPro-Dex does not have a long track record of dividend growth. News and Social Media3.8 / 5News Sentiment1.07 News SentimentPro-Dex has a news sentiment score of 1.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 13 news articles for Pro-Dex this week, compared to 1 article on an average week.Search Interest1 people have searched for PDEX on MarketBeat in the last 30 days. Company Ownership1.6 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Pro-Dex insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,351,657.00 in company stock.Percentage Held by Insiders48.00% of the stock of Pro-Dex is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions15.28% of the stock of Pro-Dex is held by institutions.Read more about Pro-Dex's insider trading history. Receive PDEX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PDEX Stock News HeadlinesPro-Dex (PDEX) Positioned for Growth as Zimmer Advances Robotic Knee PlatformNovember 18 at 9:56 AM | finance.yahoo.comAscendiant Capital Markets Forecasts Strong Price Appreciation for Pro-Dex (NASDAQ:PDEX) StockNovember 18 at 2:00 AM | americanbankingnews.comEarn $4,500 a month? Your income may count for moreEarn $4,500 or more a month? Pennie lets you explore personal loan options that consider your income, not just your credit score. Options include personal loans up to $250,000 and APRs starting at 5.99%. Checking your rate is free, and the soft credit check won't affect your score. Pennie is a loan marketplace, not a lender. Offers come from third-party partners and are not guaranteed.November 20 at 1:00 AM | Pennie Financial (Ad)Pro-Dex, Inc. Enters Into Amendment To Credit Agreement With UMB Bank, N.A. Consolidating Term Loan C And Term Loan D To USD 8,513,333.16 And Extends Maturity DatesNovember 17 at 7:31 AM | marketscreener.comMPro-Dex, Inc. reports fiscal 2027 first quarter resultsOctober 29, 2026 | msn.comPro-Dex, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2026October 29, 2026 | marketscreener.comM5 Biotech And Medical Device Stocks In Focus: Pro-Dex, Modular Medical, ENvue Medical & MoreSeptember 4, 2026 | rttnews.comPro-Dex Jumps On Higher Q4 Earnings And Revenue GrowthSeptember 4, 2026 | rttnews.comSee More Headlines PDEX Stock Analysis - Frequently Asked Questions How have PDEX shares performed this year? Pro-Dex's stock was trading at $38.48 at the beginning of the year. Since then, PDEX stock has increased by 61.4% and is now trading at $62.1050. How were Pro-Dex's earnings last quarter? Pro-Dex, Inc. (NASDAQ:PDEX) posted its quarterly earnings data on Thursday, October, 29th. The medical instruments supplier reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.67 by $0.25. The medical instruments supplier earned $20.56 million during the quarter, compared to analyst estimates of $20.40 million. Pro-Dex had a net margin of 15.12% and a trailing twelve-month return on equity of 26.18%. Who are Pro-Dex's major shareholders? Top institutional shareholders of Pro-Dex include Global Retirement Partners LLC (2.47%), State Street Corp (1.21%), Pekin Hardy Strauss Inc. (0.71%) and Apriem Advisors (0.63%). Insiders that own company stock include Kirk Richard Lee Van Jr, Alisha Charlton and Angelita Rebamontan Domingo. View institutional ownership trends. How do I buy shares of Pro-Dex? Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Pro-Dex own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pro-Dex investors own include NVIDIA (NVDA), Palantir Technologies (PLTR), Broadcom (AVGO), Taiwan Semiconductor Manufacturing (TSM), Cal-Maine Foods (CALM), Robinhood Markets (HOOD) and Kratos Defense & Security Solutions (KTOS). Company Calendar Last Earnings10/29/2026Today11/20/2026Next Earnings (Estimated)2/04/2027Fiscal Year End6/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (12m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 PDEX's financial health is in the Green zone, according to TradeSmith. PDEX has been in this zone for over 12 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:PDEX CIK788920 Webwww.pro-dex.com Phone(949) 769-3200Fax949-769-3281Employees206Year Founded1975Price Target and Rating Average Price Target for Pro-Dex$80.00 High Price Target$80.00 Low Price Target$80.00 Potential Upside/Downside+26.9%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)$3.65 Trailing P/E Ratio17.30 Forward P/E Ratio18.76 P/E GrowthN/ANet Income$13.66 million Net Margins15.12% Pretax Margin19.07% Return on Equity26.18% Return on Assets16.69% Debt Debt-to-Equity Ratio0.25 Current Ratio4.19 Quick Ratio2.49 Sales & Book Value Annual Sales$77.55 million Price / Sales2.60 Cash Flow$3.85 per share Price / Cash Flow16.38 Book Value$15.42 per share Price / Book4.09Miscellaneous Outstanding Shares3,200,000Free Float1,664,000Market Cap$201.68 million OptionableNot Optionable Beta0.12 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:PDEX) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredWorse than socialismDonald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same ec...Porter & Company | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredA Bill Would Reprice America's Gold at Market ValueThe US government still values its gold at $42 an ounce, a price Congress set in 1973. Gold trades above $4,00...Concord Gold Capital | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro-Dex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pro-Dex With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.